Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
Zhu WJ, Zhu HH, Liu YT, Lin L, Xing PY, Hao XZ, Cong MH, Wang HY, Wang Y, Li JL, Feng Y, Hu XS. Zhu WJ, et al. Among authors: liu yt. Zhonghua Zhong Liu Za Zhi. 2022 May 23;44(5):416-424. doi: 10.3760/cma.j.cn112152-20210709-00504. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 35615798 Chinese.
[Rituximab combined with short-course and intensive regimen for Burkitt leukemia: efficacy and safety analysis].
Li Y, Gong XY, Zhao XL, Wei H, Wang Y, Lin D, Zhou CL, Liu BC, Wang HJ, Li CW, Li QH, Gong BF, Liu YT, Wei SN, Zhang GJ, Mi YC, Wang JX, Liu KQ. Li Y, et al. Among authors: liu bc, liu kq, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2020 Jun 14;41(6):502-505. doi: 10.3760/cma.j.issn.0253-2727.2020.06.012. Zhonghua Xue Ye Xue Za Zhi. 2020. PMID: 32654465 Free PMC article. Chinese.
[Dasatinib combined with multi-agent chemotherapy regimen in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a prospective study from a single center].
Zhang GJ, Gong XY, Qiu SW, Zhou CL, Liu KQ, Lin D, Liu BC, Wei H, Wei SN, Li Y, Gu RX, Gong BF, Liu YT, Fang QY, Mi YC, Wang Y, Wang JX. Zhang GJ, et al. Among authors: liu bc, liu kq, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2021 Feb 14;42(2):109-115. doi: 10.3760/cma.j.issn.0253-2727.2021.02.004. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 33858040 Free PMC article. Chinese.
[Efficacy and safety of IAC regimen for relapse/refractory acute myeloid leukemia: a prospective randomized controlled study].
Li CH, Wei SN, Qiu SW, Gong BF, Gong XY, Li Y, Liu YT, Fang QY, Zhang GJ, Liu KQ, Zhou CL, Lin D, Liu BC, Wang Y, Mi YC, Wei H, Wang JX. Li CH, et al. Among authors: liu bc, liu kq, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2022 Apr 14;43(4):287-292. doi: 10.3760/cma.j.issn.0253-2727.2022.04.004. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35680626 Free PMC article. Clinical Trial. Chinese.
[Impact of duration of antibiotic therapy on the prognosis of patients with acute myeloid leukemia who had Gram-negative bloodstream infection in consolidation chemotherapy].
Gu RX, Wei H, Wang Y, Liu BC, Zhou CL, Lin D, Liu KQ, Wei SN, Gong BF, Zhang GJ, Liu YT, Zhao XL, Gong XY, Li Y, Qiu SW, Mi YC, Wang JX. Gu RX, et al. Among authors: liu bc, liu kq, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2018 Jun 14;39(6):471-475. doi: 10.3760/cma.j.issn.0253-2727.2018.06.006. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 30032562 Free PMC article. Chinese.
[Comparison of the efficacy of IA and HAD induction regimens in the treatment of patients with newly diagnosed acute myeloid leukemia: a single-center study].
Zhang CX, Qiu SW, Gong BF, Gong XY, Li Y, Liu YT, Fang QY, Zhang GJ, Liu KQ, Zhou CL, Wei SN, Lin D, Liu BC, Wang Y, Mi YC, Wei H, Wang JX. Zhang CX, et al. Among authors: liu bc, liu kq, liu yt. Zhonghua Xue Ye Xue Za Zhi. 2022 May 14;43(5):383-387. doi: 10.3760/cma.j.issn.0253-2727.2022.05.006. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35680595 Free PMC article. Chinese.
1,343 results